{"id":"https://openalex.org/W4210693060","doi":"https://doi.org/10.1016/j.ijpharm.2022.121557","title":"Prediction of the impact of lubrication on tablet compactibility","display_name":"Prediction of the impact of lubrication on tablet compactibility","publication_year":2022,"publication_date":"2022-02-05","ids":{"openalex":"https://openalex.org/W4210693060","doi":"https://doi.org/10.1016/j.ijpharm.2022.121557","pmid":"https://pubmed.ncbi.nlm.nih.gov/35134481"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2022.121557","doi":"https://doi.org/10.1016/j.ijpharm.2022.121557","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2022.121557","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091318855","display_name":"Daniel Puckhaber","orcid":"https://orcid.org/0000-0003-2762-4019","observed_orcids":["https://orcid.org/0000-0003-2762-4019"]},"institutions":[{"id":"https://openalex.org/I94509681","display_name":"Technische Universit\u00e4t Braunschweig","ror":"https://ror.org/010nsgg66","country_code":"DE","type":"education","lineage":["https://openalex.org/I94509681"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Daniel Puckhaber","raw_affiliation_strings":["Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany; Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany. Electronic address: d.puckhaber@tu-braunschweig.de","Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany","Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany; Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany. Electronic address: d.puckhaber@tu-braunschweig.de","institution_ids":["https://openalex.org/I94509681"]},{"raw_affiliation_string":"Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany","institution_ids":["https://openalex.org/I94509681"]},{"raw_affiliation_string":"Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany","institution_ids":["https://openalex.org/I94509681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057988130","display_name":"Jan Henrik Finke","orcid":"https://orcid.org/0000-0001-6936-9795","observed_orcids":["https://orcid.org/0000-0001-6936-9795"]},"institutions":[{"id":"https://openalex.org/I94509681","display_name":"Technische Universit\u00e4t Braunschweig","ror":"https://ror.org/010nsgg66","country_code":"DE","type":"education","lineage":["https://openalex.org/I94509681"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jan Henrik Finke","raw_affiliation_strings":["Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany; Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany. Electronic address: j.finke@tu-braunschweig.de","Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany","Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany; Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany. Electronic address: j.finke@tu-braunschweig.de","institution_ids":["https://openalex.org/I94509681"]},{"raw_affiliation_string":"Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany","institution_ids":["https://openalex.org/I94509681"]},{"raw_affiliation_string":"Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany","institution_ids":["https://openalex.org/I94509681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112906801","display_name":"Sarah David","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sarah David","raw_affiliation_strings":["Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: sarah.david@novartis.com","Novartis Pharma AG, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: sarah.david@novartis.com","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081515892","display_name":"Mauro Serratoni","orcid":"https://orcid.org/0009-0009-5049-0750","observed_orcids":["https://orcid.org/0009-0009-5049-0750"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Mauro Serratoni","raw_affiliation_strings":["Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: mauro.serratoni@novartis.com","Novartis Pharma AG, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: mauro.serratoni@novartis.com","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058815782","display_name":"Umair Zafar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Umair Zafar","raw_affiliation_strings":["Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: umair.zafar@novartis.com","Novartis Pharma AG, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: umair.zafar@novartis.com","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112666049","display_name":"Edgar John","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Edgar John","raw_affiliation_strings":["Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: edgar.john@novartis.com","Novartis Pharma AG, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: edgar.john@novartis.com","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064985806","display_name":"Michael Juhnke","orcid":"https://orcid.org/0000-0001-5574-2157","observed_orcids":["https://orcid.org/0000-0001-5574-2157"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michael Juhnke","raw_affiliation_strings":["Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: michael.juhnke@novartis.com","Novartis Pharma AG, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: michael.juhnke@novartis.com","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005901248","display_name":"Arno Kwade","orcid":"https://orcid.org/0000-0002-6348-7309","observed_orcids":["https://orcid.org/0000-0002-6348-7309"]},"institutions":[{"id":"https://openalex.org/I94509681","display_name":"Technische Universit\u00e4t Braunschweig","ror":"https://ror.org/010nsgg66","country_code":"DE","type":"education","lineage":["https://openalex.org/I94509681"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Arno Kwade","raw_affiliation_strings":["Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany; Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany. Electronic address: a.kwade@tu-braunschweig.de","Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany","Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany; Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany. Electronic address: a.kwade@tu-braunschweig.de","institution_ids":["https://openalex.org/I94509681"]},{"raw_affiliation_string":"Center of Pharmaceutical Engineering (PVZ), Technische Universit\u00e4t Braunschweig, Franz-Liszt-Stra\u00dfe 35A, 38106 Braunschweig, Germany","institution_ids":["https://openalex.org/I94509681"]},{"raw_affiliation_string":"Institute for Particle Technology, Technische Universit\u00e4t Braunschweig, Volkmaroder Stra\u00dfe 5, 38104 Braunschweig, Germany","institution_ids":["https://openalex.org/I94509681"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5091318855"],"corresponding_institution_ids":["https://openalex.org/I94509681"],"apc_list":{"value":4050,"currency":"USD","value_usd":4050},"apc_paid":null,"fwci":4.3381,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.97079223,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"617","issue":null,"first_page":"121557","last_page":"121557"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10615","display_name":"Granular flow and fluidized beds","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2206","display_name":"Computational Mechanics"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10615","display_name":"Granular flow and fluidized beds","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2206","display_name":"Computational Mechanics"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12932","display_name":"Powder Metallurgy Techniques and Materials","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2210","display_name":"Mechanical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lubricants","display_name":"lubricants","score":0.8429999947547913},{"id":"https://openalex.org/keywords/tablet-tensile-strength","display_name":"tablet tensile strength","score":0.9150000214576721},{"id":"https://openalex.org/keywords/magnesium-stearate","display_name":"magnesium stearate","score":0.843999981880188},{"id":"https://openalex.org/keywords/sodium-stearyl-fumarate","display_name":"sodium stearyl fumarate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/microcrystalline-cellulose","display_name":"microcrystalline cellulose","score":0.9789999723434448},{"id":"https://openalex.org/keywords/lactose","display_name":"lactose","score":0.9879999756813049},{"id":"https://openalex.org/keywords/empirical-model","display_name":"empirical model","score":0.5960000157356262},{"id":"https://openalex.org/keywords/lubricant-concentration","display_name":"lubricant concentration","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C2778572730","wikidata":"https://www.wikidata.org/wiki/Q416713","display_name":"Magnesium stearate","level":3,"score":0.9526506662368774},{"id":"https://openalex.org/C2779849058","wikidata":"https://www.wikidata.org/wiki/Q7673462","display_name":"Tableting","level":2,"score":0.9239329695701599},{"id":"https://openalex.org/C2779351475","wikidata":"https://www.wikidata.org/wiki/Q417374","display_name":"Microcrystalline cellulose","level":3,"score":0.9115622043609619},{"id":"https://openalex.org/C2780874159","wikidata":"https://www.wikidata.org/wiki/Q323840","display_name":"Lubricant","level":2,"score":0.7771931886672974},{"id":"https://openalex.org/C112950240","wikidata":"https://www.wikidata.org/wiki/Q76005","display_name":"Ultimate tensile strength","level":2,"score":0.7581722736358643},{"id":"https://openalex.org/C175804951","wikidata":"https://www.wikidata.org/wiki/Q3268188","display_name":"Diluent","level":2,"score":0.6677702069282532},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.5942652225494385},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.5455394387245178},{"id":"https://openalex.org/C184608416","wikidata":"https://www.wikidata.org/wiki/Q1455803","display_name":"Lubrication","level":2,"score":0.4989142417907715},{"id":"https://openalex.org/C196715460","wikidata":"https://www.wikidata.org/wiki/Q1414356","display_name":"Compaction","level":2,"score":0.42888781428337097},{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.41945961117744446},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.3993355333805084},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.2548425793647766},{"id":"https://openalex.org/C2779251873","wikidata":"https://www.wikidata.org/wiki/Q80294","display_name":"Cellulose","level":2,"score":0.24902182817459106},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.22208631038665771},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21724668145179749},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12640663981437683},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.08024212718009949}],"mesh":[{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008153","descriptor_name":"Lubrication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013229","descriptor_name":"Stearic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013718","descriptor_name":"Tensile Strength","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054327","descriptor_name":"Lubricants","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ijpharm.2022.121557","doi":"https://doi.org/10.1016/j.ijpharm.2022.121557","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2022.121557","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:35134481","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35134481","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320318442","display_name":"Novartis Animal Health","ror":null},{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1779131835","https://openalex.org/W1967869169","https://openalex.org/W1985068217","https://openalex.org/W1986187430","https://openalex.org/W1994191351","https://openalex.org/W1995965908","https://openalex.org/W1998089412","https://openalex.org/W2000364540","https://openalex.org/W2001003341","https://openalex.org/W2007269426","https://openalex.org/W2012022085","https://openalex.org/W2013928324","https://openalex.org/W2014885111","https://openalex.org/W2020410921","https://openalex.org/W2020636197","https://openalex.org/W2021052230","https://openalex.org/W2023525795","https://openalex.org/W2027307394","https://openalex.org/W2038847057","https://openalex.org/W2041002778","https://openalex.org/W2041320373","https://openalex.org/W2045592738","https://openalex.org/W2046349020","https://openalex.org/W2057690239","https://openalex.org/W2064617635","https://openalex.org/W2069020417","https://openalex.org/W2071116450","https://openalex.org/W2086145809","https://openalex.org/W2089934915","https://openalex.org/W2091640731","https://openalex.org/W2111052106","https://openalex.org/W2116826288","https://openalex.org/W2121818014","https://openalex.org/W2155627309","https://openalex.org/W2155768016","https://openalex.org/W2159569807","https://openalex.org/W2525986801","https://openalex.org/W2748456649","https://openalex.org/W2753136537","https://openalex.org/W3015175791","https://openalex.org/W3043927864","https://openalex.org/W3134874888"],"related_works":["https://openalex.org/W4417138113","https://openalex.org/W7168354537","https://openalex.org/W4362717275","https://openalex.org/W4320717761","https://openalex.org/W3093021835","https://openalex.org/W2091640731","https://openalex.org/W1969412672","https://openalex.org/W4387040079","https://openalex.org/W2784075391","https://openalex.org/W1986187430"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-02-08T00:00:00"}